Genedata AG. (6/1/09). "Press Release: Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities. Expressionist 5.2 Will Demo at the 57th ASMS Conference". Philadelphia, PA.

	Organisation	Genedata AG
	Group	Genedata (Group)
	Organisation 2	University of Alabama, UAB Proteomics and Mass Spectrometry Facility
	Group	University of Alabama at Birmingham (UAB)
	Product	Genedata Expressionist® (s/w)
	Product 2	mass spectrometry (MS)
	Index term	Univ Alabama Birmingham–Genedata: Expressionist s/w, 200906 supply existent use at Proteomics Facility at AUB Comprehensive Cancer Center
	Person	Pfannes, Othmar (Genedata 200406 CEO)
	Person 2	Mobley, James (Univ Alabama 200906 Comprehensive Cancer Center Proteomics Facility)

Genedata, a leading provider of in silico solutions for pharmaceutical R&D and related life sciences, today announced the release of Expressionist 5.2 with enhanced capabilities for Mass Spectrometry (MS)-based biomarker discovery. Included in the Expressionist system are the advanced Refiner MS and Analyst modules, which process and analyze metabolomic and proteomic raw MS data and provide sophisticated statistical analysis capabilities for large volume data sets. Expressionist 5.2 will be demonstrated at the 57th ASMS Conference on Mass Spectrometry, May 31 - June 4, 2009, Booth 133 at the Pennsylvania Convention Center.

"Genedata's continued investment in Expressionist is invaluable and the new Expressionist system will drastically change the ways in which we are able to probe experimental systems," commented Professor James Mobley, director of the Comprehensive Cancer Center Proteomics Facility at the University of Alabama. "Expressionist enables us to better understand underlying biological mechanisms and the support for labeled MS data allows us to address an ever-larger array of experimental protocols."

In addition to supporting ABI Wiff files, version 5.2 of Refiner MS adds Thermo Exactive and GC-MS as well as Agilent Q-TOF and GC-MS instruments to the wide list of already supported hardware platforms and vendor formats. Building on a powerful technology hub concept for raw MS data processing, peak identification and annotation tools in Expressionist have been enhanced to offer direct links to search engines and databases such as MASCOT or HMDB. Additionally, improved library searches are possible via the computation of retention-time indices.

"The release of Expressionist 5.2 underscores our continued commitment to support all types of omics technologies. In particular we are proud to provide innovative software for high throughput peak processing and identification for large MS datasets at a time when this type of data has become more and more standard in proteomics and metabolomics projects," said Dr. Othmar Pfannes, CEO of Genedata. Expressionist features support for labelled workflows using Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) and Multiple Reaction Monitoring (MRM) targeted analysis. Usability improvements include blank chromatogram subtraction and spectrum peak clustering.

"We are delighted by the market acceptance of our MS offering for proteomics and metabolomics in pharmaceutical, biotechnology, agricultural and academic as well as government R&D projects," Dr. Pfannes continued."I am proud of our team's ability to quickly provide solutions for a wide variety of requests for standardization and automation of MS data analysis processes."

Editorial Note: Genedata will be exhibiting at Booth 133 at the ASMS conference. To schedule a briefing and product demo, contact: Jackie Thrasivoulos, +1 508 881 3109, jackie.thrasivoulos@genedata.com

About Genedata
Genedata develops and globally markets sophisticated computational solutions for drug discovery and related research processes in the life sciences. Genedata's solutions enable scientists to process, integrate, analyze, and manage large and complex experimental data sets generated by high throughput technologies. Solutions include Genedata Phylosopher® for target discovery and integrative biological data management, Genedata Screener® for automated high throughput screening and high content screening, and Genedata Expressionist® for biomarker discovery and personalized medicine. Founded in 1997, Genedata is privately held, with headquarters in Basel, Switzerland, and offices in Boston and San Francisco, USA, Konstanz and Munich, Germany and Tokyo, Japan. For more information, please visit www.genedata.com.

Contact
Allison Kurz
Genedata
Marketing & Communications
Phone: +41 61 511 8459
communications(at)genedata.com

Jackie Thrasivoulos
Genedata
Public Relations
Phone +1 508 881 3109
jackie.thrasivoulos(at)genedata.com

Disclaimer
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

All product and service names mentioned are the trademarks of their respective companies.

Record changed: 2011-11-25

Follow Us!

Top News

Upcoming Events

Associations

Partners

Genedata AG. (6/1/09). "Press Release: Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities. Expressionist 5.2 Will Demo at the 57th ASMS Conference". Philadelphia, PA.

More documents for Genedata (Group)